Selectivity was demonstrated by the finding that only ALK‐rearranged cancer cells, but not normal lung epithelial cells, showed sensitivity to ALK inhibitors (ALKi) (Fig. 2A–C and Fig. S2B,C). Here, ALK is linked to cancer.